Eleventh Five-Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930010);National Science Foundation of China(Grant No.81172915);a grant from Major New Drug Research and Development Platform of Peking University(GrantNo.2009ZX09301010)
YSY01-A, as a novel proteasome inhibitor, has shown remarkable proliferation inhibitory effect on certain types of tumor cells. However, few studies have reported its effect on non-small cell lung cancer (NSCLC), an...
Eleventh Five-Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930-010);National Science Foundation of China(Grant No.81172915);a grant from Major New Drug Research and Development Platform of PekingUniversity(Grant No.2009ZX09301-010)
As a novel proteasome inhibitor, remarkable proliferation inhibitory effect of compound YSY-01A was shown on tumor cells in previous studies. However, few studies has reported its effect on gastric cancer and related ...
Eleventh Five-Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930-010);National Science Foundation of China(Grant No.81172915);a grant from Major New Drugs Research and Development Platform of Peking University(Grant No.2009ZX09301-010)
YSY-01A has shown proliferation inhibitory activity to certain types of tumor cells by inhibiting proteasome. How- ever, its effect on autophagy, which is related with the ubiquitin proteasome pathway (UPP), remains...
Eleventh Five Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930010)
Compound SLXM-2, a derivative of cyclophosphamide (CTX), has shown potent growth-inhibitory effect on tumor cells with low toxicity in previous studies. However, the mechanism of its anti-tumor effect, especially on...
Eleventh Five-Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930-010);National Science Foundation of China(Grant No.81172915);a grant from Major New Drugs Research and Development Platform of Peking University(Grant No.2009ZX09301-010)
Compound YSY-01A, a recently synthesized proteasome inhibitor, has shown potent growth-inhibitory effect on tumor cells in previous researches. However, the mechanism of its inhibitory effects, especially on cell cycl...
China International Science and Technology Cooperation Program for Key Projects (Grant No. 2008DFA31070)
Compound 209 is a newly synthesized dithiocarbamate derivative with antiproliferation activity in vitro, however, its antitumor effect in vivo and the underlying mechanisms have yet to be identified. We explored the a...
Eleventh Five-Year Plan for National Science and Technology Major Project (Grant No.2009ZX0930-010);National Science Foundation of China (NSFC81172915);A grant from Major New Drugs Research and Development Platform of Peking University (Grant No.2009ZX09301-010)
Compound YSY-01A, a recently synthesized proteasome inhibitor, has shown potent growth-inhibitory effect on tumor cells in previous researches. However, the mechanism of its inhibitory effects, especially on cell cycl...